QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.054544v1 307/1/306    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mottino, A. D. Articles by Vore, M. Search for Related Content PubMed PubMed Citation Articles by Mottino, A. D. Articles by Vore, M.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Biliary Secretion of Glutathione in Estradiol 17-D-Glucuronide-Induced Cholestasis

Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky (M.W., J.M.V.R., M.V.); and Institute of Experimental Physiology, School of Biochemical and Pharmaceutical Sciences, Rosario, Argentina (A.D.M., L.M.V.)

Estradiol-17-D-glucuronide (E2-17G) induces an acute but reversible inhibition of bile flow after its intravenous administration to rats, due in part to the endocytic retrieval of the canalicular multidrug resistance-associated transporter protein 2 and the bile salt export pump, transporters that contribute to bile flow. Decreased bile salt-independent bile flow (BSIF) is also involved and persists during the phase of recovery from cholestasis. Because glutathione and are major contributors to BSIF, we evaluated changes in their biliary excretion and the hepatic content of total glutathione during E2-17G-induced cholestasis. E2-17G acutely decreased bile flow and biliary excretion of total glutathione by about 80%; glutathione excretion was still inhibited at 80 min and 120 min, even though bile flow was partially and totally restored, respectively. Neither liver glutathione content nor the proportions of oxidized glutathione in bile and liver were affected by E2-17G at any time. concentrations in bile were unchanged, so that secretion paralleled variations in bile flow. In the isolated perfused liver, addition of E2-17G decreased both bile flow and the biliary concentration of glutathione, whereas addition of its noncholestatic isomer estradiol-3-D-glucuronide (E2-3G) did not inhibit bile flow, but significantly reduced the concentration of glutathione in bile. The bile:liver concentration ratios of glutathione were significantly decreased in vivo by E2-17G and in the perfused liver by E2-17G and E2-3G. These data indicate that E2-17G cis-inhibits the canalicular transport of glutathione and thus contributes to the cholestatic effect by inhibiting BSIF.

Address correspondence to: Dr. Mary Vore, Graduate Center for Toxicology, 306 Health Sciences Research Bldg., University of Kentucky, Lexington, KY 40536-0305. E-mail: maryv{at}uky.edu

This article has been cited by other articles:

				H. Sun, L. Liu, and K. S. Pang Increased Estrogen Sulfation of Estradiol 17beta-D-Glucuronide in Metastatic Tumor Rat Livers J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 818 - 831. [Abstract] [Full Text] [PDF]

				M. L. Ruiz, S. S. M. Villanueva, M. G. Luquita, M. Vore, A. D. Mottino, and V. A. Catania ETHYNYLESTRADIOL INCREASES EXPRESSION AND ACTIVITY OF RAT LIVER MRP3 Drug Metab. Dispos., June 1, 2006; 34(6): 1030 - 1034. [Abstract] [Full Text] [PDF]

				A. D. Mottino, F. A. Crocenzi, E. J. S. Pozzi, L. M. Veggi, M. G. Roma, and M. Vore Role of microtubules in estradiol-17{beta}-D-glucuronide-induced alteration of canalicular Mrp2 localization and activity Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G327 - G336. [Abstract] [Full Text] [PDF]

				P. M. Gerk, W. Li, and M. Vore ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE Drug Metab. Dispos., October 1, 2004; 32(10): 1139 - 1145. [Abstract] [Full Text] [PDF]